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Abstract PCR primers were designed from the known amino 
acid (aa) sequence for human red blood cell thioltransferase 
(hRBC TTase) and the known cDNA sequence for pig liver 
TTase (82% homologous) and used to amplify thioltransferase 
from a pool of human brain cDNAs. The PCR product was 
inserted into the pKK233-2 expression vector. The DNA se- 
quence of the insert agreed with the aa sequence. High level 
expression of the enzyme was accomplished in E. coli, and West- 
ern blot analysis confirmed its identity. Recombinant TTase dis- 
played catalytic properties indistinguishable from natural hRBC 
TTase. 
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2. Materials and methods 
2.1. Materials 
Glutathione and glutathione disulfide reductase were purchased 
from Sigma. NADPH was obtained from Boehringer Mannheim. S- 
sulfocysteine and L-cysteinyl-glutathione w re purchased from Toronto 
Research Chemicals, Inc. DNA primers were synthesized in a 380B or 
394 DNA synthesizer from Applied Biosystems. Taq Polymerase, T4 
DNA ligase, Klenow, restriction enzymes, and subcloning efficiency 
DH5~ cells were from Gibco BRL. Pfu polymerase was from Strat- 
agene. Sephadex G-75 gel filtration medium was obtained from Phar- 
macia. The micro BCA protein assay was obtained from Pierce. ISS 
Pro-Blue system was purchased from Integrated Separation Systems. 
Wizard mini and maxi prep kits were from Promega, and the Qiaex 
DNA purification system was purchased from Qiagen. All other chem- 
icals were at least reagent grade from standard sources. 
1. Introduction 
Thioltransferase (TTase), also known as glutaredoxin, is a 
member of the thiol-disulfide oxidoreductase (TDOR) family 
which also includes thioredoxin and protein disulfide isom- 
erase. These enzymes are believed to be involved in regulating 
sulfhydryl homeostasis through catalysis of thiol-disulfide in- 
terchange reactions [1-4]. The environment inside cells is pre- 
dominantly reducing due to high levels of reduced glutathione 
(GSH); however, oxidative stress can alter this environment 
allowing exposed cellular thiols to become oxidized. Oxidation 
of exposed protein thiols can lead to protein inactivation [1,4], 
and it has been postulated that TDOR enzymes function to 
protect or repair sensitive sulfhydryls in times of oxidative 
stress [1-4]. 
TTase is a small (MW = 11.7 kDa) cytosolic protein that 
displays a high degree of amino acid sequence homology among 
mammalian species, and it is selective for glutathione-contain- 
ing mixed disulfide substrates [1,5]. The actual physiological 
functions of TTase remain unresolved, and investigation of 
these functions would be greatly facilitated with recombinant 
enzyme technology. Here we report the cloning, expression and 
characterization of recombinant human TTase. 
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2.2. Cloning of cDNA 
Primers were designed based on the amino acid sequence of hRBC 
TTase that we determined previously [6] and the cDNA sequence for 
pig liver TTase [7] which has 82% amino acid sequence homology [6,8]. 
NcoI and HindIII restriction sites were added to the ends of the 5' and 
3' primers, respectively, to enable easy insertion of the TTase cDNA 
into pKK233-2. This vector was chosen because previously it was 
shown to direct high level expression of pig liver TTase [9]. The synthe- 
sized primers were used in the polymerase chain reaction (PCR) to 
amplify TTase cDNA from the template, a pool of human brain 
cDNAs. The human brain cDNA was obtained from reverse transcrip- 
tion reactions with random primers and RNA purified from the cere- 
bral cortex of several human brains. 
2.3. Plasmid analysis 
The ligated vector was transformed into DH5~ cells, and several 
clones were chosen for analysis. The presence of the TTase cDNA insert 
was verified by restriction digestion analysis and resulting positive 
clones were designated pCC-TT1 and pCC-TT2. 
2.4. Sequence analysis 
Sequences of the CC-TT1 and CC-TT2 inserts in both the 3 and 5 
prime directions, were obtained by automated fluorescence DNA se- 
quencing, in the core facility of the Cleveland Clinic Foundation. 
2.5. Expression of recombinant thioltransferase 
Expression of TTase from pCC-TT1 (or pCC-TT2) was done in 
DH5~ E. coli cells. Cells in log phase were treated with 2 mM isopropyl- 
~-l>thiogalactopyranoside (IPTG), and grown for an additonal 6 h. 
The cells were centrifuged (10,000 rpm in a JA-20 rotor for 30 min), 
resuspended in 10 mM sodium phosphate, pH 7.5 and then lysed by 
passage through a French Press. The lysed cells were centrifuged to 
remove cell debris and the supernatant was concentrated by passage 
through an Amicon ultrafiltration device with a YM3 filter. The con- 
eentrated sample was purified using a Sephadex G-75 column (2.5 x 130 
cm) equilibrated and eluted with 10 mM sodium phosphate, pH 7.5 (see 
section 3). 
2.6. Analysis" of purified recombinant thioltransferase 
The enzymatic activity of recombinant TTase was analyzed using 
spectrophotometric and radiolabel assays as described previously 
[5,10]. In addition, the radiolabel assay was done with two different 
mixed disulfide substrates [35S]BSA-SSCysteine and [35S]BSA-SSG, 
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which were prepared as described previously [5]. The two different 
substrates were used to verify the substrate selectivity of the recombi- 
nant enzyme relative to natural hRBC TTase. The amount of protein 
in various samples was quantified using the BCA assay according to 
manufacturer's instructions (Pierce). SDS-PAGE and Western blot 
analyses were performed as previously described [11]. 
3. Results 
3.1. Cloning 
TTase was amplified using primers directed against the 
known aa sequence of hRBC TTase and the cDNA sequence 
of pig liver TTase. This amplified cDNA was purified, digested, 
and ligated into pKK233-2 (Fig. 1) to create the pCC-TTI 
(pCC-TT2) plasmid. The result was verified by restriction di- 
gest analysis with XhoI (unique to the TTase insert), NcoI and 
HindlII. The insert from the original TTase clone was se- 
quenced, and it corresponded to the amino acid sequence that 
we reported previously [6], except for a single amino acid differ- 
ence at position 55 (tyrosine instead of asparagine). Since the 
known amino acid sequence [6] and the cDNA sequence of 
brain TTase recently published by Fernando et al. [12] con- 
tained asparagine at this position and because the change was 
caused by a single base difference in the codon, it was inter- 
preted as an error by taq polymerase. Therefore we designed 
new primers to mutate the altered base back to wild type. Pfu 
polymerase was used instead of taq in these PCR reactions to 
ensure greater fidelity during elongation. Fig. 2 shows the 
cDNA sequence obtained from this second clone pCC-TT2 
which corresponds exactly to the amino acid sequence that we 
determined previously [6] and which was confirmed by Padilla 
et al. [8]. The cDNA reported by Fernando et al. [12] differs 
from both our sequence and that of Padilla et al. [8] by a valine 
instead of leucine at position 96. Since the leucine at position 
96 is well conserved throughout mammalian species [1], it is 
interpreted as wild type and was not changed. The TTase insert 
has also been removed from the pKK233-2 parent vector and 
inserted into pBluescript, as well as into the mammalian expres- 
sion vector pREP10. 
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Fig. 2. DNA sequence and corresponding amino acid sequence of 
thioltransferase [6]. 
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Fig. 1. Cloning strategy for recombinant human thioltransferase. 
3.2. Expression 
Yields of TTase from several DH5~ E. coli preparations have 
ranged between 3-13% of total cytosolic protein. Some prepa- 
rations indicated that the effect of lPTG is variable, but this was 
not studied separately. The specific activity of recombinant 
TTase obtained from several preparations after purification by 
gel filtration chromatography as ranged from 60-104 units/ 
mg, corresponding to 54-94% purity by comparison to the 
specific activity of pure hRBC TTase [I0]. The relative purity 
was confirmed by SDS-PAGE analysis (Fig. 3), where a single 
characteristic band which corresponds to the molecular weight 
of TTase was observed in the sample of purified protein from 
lysates of bacteria containing pCC-TT2; no such band ap- 
peared upon SDS-PAGE analysis of purified protein from ly- 
sates of bacteria transformed with pKK233-2 (plasmid without 
TTase inserted). Western blot analysis with antibodies to hRBC 
TTase revealed immunoreactive bands at the appropriate mo- 
lecular weight (Fig. 4). 
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Fig. 3. Analysis of purified recombinant human thioltransferase. SDS- 
PAGE gel (6% stacking, 15% gel) was run for approximately 1 h at 
5 mA and developed with ISS Pro Blue stain, as directed by the manu- 
facturer. Lane 1:1.5 pg thioredoxin; lane 2: no sample; lane 3:2 pg of 
purified, concentrated protein from cells with pKK233-2 (no insert); 
lane 4: molecular weight standards kDaltons; lane 5:1.5/2g hRBC 
TTase; lane 6: no sample; lane 7:2 pg of purified, concentrated protein 
from cells with pCC-TT2 (TTase insert). 
3.3. Catalytic characteristics 
The recombinant and natural TTase were initially compared 
using the spectrophotometric assay, and their activities were 
indistinguishable. Further, using the spectrophotometric assay 
with recombinant TTase and hRBC TTase at equivalent enzy- 
matic activities, the dependence of the rates of disulfide reduc- 
tion on substrate concentration were indistinguishable (Fig. 5). 
Moreover, as previously reported for hRBC TTase [5], recom- 
binant TTase catalyzed ethiolation of glutathione-mixed di-
sulfides only (Table 1). Thus, the catalytic characteristics of 
recombinant TTase were indistinguishable from natural hRBC 
TTase both with respect to substrate selectivity and kinetic 
characteristics. 
4. Discussion 
This work reports the cloning, expression, and characteriza- 
tion of human TTase. The protein was purified using a simple 
procedure that produces TTase faster, and at higher yields than 
isolation of the natural hRBC enzyme [10]. Two other reports 
on the cDNA sequence for human TTase have appeared, but 
expression and characterization of the enzyme were not re- 
ported [8,12]. However more recently and simultaneously with 
our preliminary presentation of the current data [13] at the 1995 
ASBMB/ACS meeting in San Francisco the cloning and expres- 
sion of human placental TTase was presented by Meyer and 
Wells [14]. 
TTase is thought o be involved in a variety of physiological 
functions including enzyme regulation, and cellular protection 
[14]; and further it has been postulated to be involved in signal 
transduction [1,3]. Glutathionylation f proteins has been ob- 
served in a variety of different cells [15 19], and it has been 
postulated that TTase may catalyze both the formation and 
breakdown of glutathionylated proteins. The function of pro- 
Table 1 
Specificity of natural and recombinant thioltransferase 
Source of Enzyme-mediated Enzyme-mediated 
thioltransferase dethiolation of dethiolation of 
BSA-S-SG a nmol BSA-S-SCys b nmol 
[35S]SG/min/nmol [35S]SC/mirdnmol 
TTase TTase 
hRBC TTase 332 + 13 min -~ c None Detected 
Recombinant 328 + 26 min -1 a None Detected 
Release of glutathionyl ([35S]SG) or cysteinyl ([35S]SC) equivalents from 
the labeled BSA mixed disulfide substrates was measured using the 
radiolabel dethiolation assay [5]. Non-enzymatic rates were subtracted 
from the overall rates. 
a Reactions were done at 30°C and contained 0.5 mM GSH, 0.1 mM 
[35S]BSA-SSG and several concentrations of TTase (8-50 nM), at 
pH = 7,5. 
b Reactions were done at 30°C and contained 1 mM GSH, and 0.5 mM 
[35S]BSA-SSCysteine and several concentrations of TTase (8-50 nM), 
at pH = 7.5. 
c Value represents average of 9 experiments + standard error. 
a Value represents average of 7 experiments + standard error. 
tein glutathionylation is not yet known, however, it is possible 
that glutathionylation acts to protect cellular proteins by rever- 
sibly binding to sensitive sulfhydryls during times of oxidative 
stress [1]. Recently was reported [20] that TTase levels are lower 
in a variety of chemically transformed cells when compared to 
the untransformed cell type, suggesting that variations in TTase 
levels may have important cellular consequences. The creation 
of mammalian cell lines that over- and under-express TTase will 
provide an experimental paradigm in which the cellular func- 
tions of TTase can be studied more directly, including the effect 
TTase has on protein glutathionylation. I  addition, high levels 
i -  
t.- 
..Q 
o Eo 
rn  o 
r r  • 
• e- 0 n"~ 
C) x ooo 
46 
30 
21.5 
14.3 
Fig. 4. Western blot analysis of recombinant human thioltransferase. 
SDS-PAGE gel treated the same as described under Fig. 3 except hat 
the gel was transblotted to nitrocellulose for 45 min at 1 A prior to 
developing. The nitrocellulose blot was treated with anti-TTase [11], 
and a horseradish peroxidase conjugated secondary antibody, and then 
developed with the chromogenic substrate 4-Chloro-1-Naphthol. Lane 
1:1/2g of TTase in concentrated pre-column lysate; lane 2: no sample; 
lane 3: no sample; lane 4:1.5/tg hRBC TTase; lane 5: molecular weight 
markers; lane 6:1 pg purified, concentrated recombinant TTase; lane 
7: no sample; lane 8:1.5/.tg E. coli thioredoxin. 
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Comparison of the Substrate ConcentraUon Dependence 
of Recombinant vs Human Thioltransferase 
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Fig. 5. Substrate concentration dependence for natural and recombi- 
nant thioltransferases. Reactions contained 0.2 mM NADPH, 0.5 mM 
GSH, 2 units/ml GSSG reductase in 0.1 M potassium phosphate, pH 
7.4, and initiated with 2-500 mM cysteinylglutathione, i  a total volume 
of 0.2 ml. o recombinant TTase; [] human red blood cell TTase. Rates 
were measured as time dependent changes in absorbance at340 rim. The 
rates of non-enzymatic reactions were subtracted, and the difference 
plotted against cysteinylglutathione concentration. 
of pure, wild type, and eventually mutant TTase protein will 
facilitate a variety of in vitro experiments, including structural 
studies with NMR.  
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